简体
简体中文
繁體中文

Nuwellis, Inc. NUWE

已收盘 02-06 16:00:00 美东时间

2.61

+0.140

+5.67%

华盛通华盛通
立即下载
  • 最 高4.9399
  • 今 开2.52
  • 成交量 11.91万股
  • 最 低 1.709
  • 昨 收 2.47
  • 总市值 2.75万
  • 52周最高 4.9399
  • 市盈率 --
  • 换手率 1130.59%
  • 52周最低 0.00
  • 委 比 70.21%
  • 总股本 1.05万
  • 历史最高 4.9399
  • 量 比 0.29
  • 振 幅 130.81%
  • 历史最低 0.00
  • 每 手 1
  • 风险率 2.81%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Nuwellis Appoints Carisa Schultz CFO, Effective Feb. 2

    Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026.Ms.

    01-30 21:06

  • Dow Falls Over 300 Points; General Motors Posts Upbeat Earnings

    U.S. stocks traded mixed this morning, with the Dow Jones index falling more th...

    01-27 22:38

  • Nuwellis Announces A Leading Northeastern U.S. Children's Hospital Has Initiated An Aquadex Ultrafiltration Program

    Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children's hospital has initiated

    2025-12-04 21:16

  • Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

    Nuwellis, Inc. announces a public offering of 406,755 common shares and warrants, priced at $0.30 per share and $0.2999 for pre-funded warrants. Proceeds will support working capital and potential acquisitions. The company, based in Minneapolis, focuses on treating fluid overload with its Aquadex SmartFlow system.

    2025-06-09 13:15

  • Nuwellis Q4 2024 GAAP EPS $(0.44) Misses $(0.43) Estimate, Sales $2.32M Miss $2.46M Estimate

    Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 99.19 percent increase over losses of $(54.48) per share from the

    2025-03-11 20:03

  • Earnings Scheduled For March 11, 2025

    Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...

    2025-03-11 16:32

  • 古特拉盘中异动 大幅下跌5.44%报0.661美元

    北京时间2024年10月24日02时32分,古特拉(CUTR.us)股票出现异动,股价大幅下挫5.44%。截至发稿,该股报0.661美元/股,成交量12.0112万股,换手率0.59%,振幅3.12%。 最近的财报数据显示,该股实现营业收入34.38百万美元,净利润-24.68百万美元,每股收益-1.23美元,毛利6.27百万美元,市盈率-0.09倍。 机构评级方面,在所有4家参与评级的机构中,25%的券商给予买入建议,75%的券商给予持有建议,无券商给予卖出建议。 古特拉股票所在的医疗器械行业中,整体跌幅为0.49%。其相关个股中,Tenon Medical Inc C/Wts 16/06/...

    2024-10-24 02:32

  • 英特格拉生命科学盘中异动 大幅上涨5.19%

    北京时间2024年10月11日02时31分,英特格拉生命科学(IART.us)股票出现波动,股价快速上涨5.19%。截至发稿,该股报19.04美元/股,成交量55.3162万股,换手率0.71%,振幅6.30%。 最近的财报数据显示,该股实现营业收入4.18亿美元,净利润-12.40百万美元,每股收益-0.16美元,毛利2.32亿美元,市盈率65.52倍。 机构评级方面,在所有14家参与评级的机构中,21%的券商给予买入建议,50%的券商给予持有建议,29%的券商给予卖出建议。 英特格拉生命科学股票所在的医疗器械行业中,整体跌幅为0.36%。其相关个股中,Spectral Ai, Inc.、S...

    2024-10-11 02:31

  • Nuwellis Prices $916,000 Registered Direct Offering -- Shares Slump Pre-Bell

    09:33 AM EDT, 08/23/2024 (MT Newswires) -- Nuwellis (NUWE) said Friday that it is selling 496,901 common shares at a per-share price of $1.845 to certain institutional investors in a registered direct offering priced at-the-market under Nasdaq rules. The company said that in a concurrent private pla...

    2024-08-23 21:33